Literature DB >> 8079657

Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells.

J R Harrison1, J A Lorenzo, H Kawaguchi, L G Raisz, C Pilbeam.   

Abstract

The mechanism by which interleukin-1 (IL-1) and transforming growth factor alpha (TGF-alpha) regulate prostaglandin synthesis has been examined in the clonal mouse osteoblastic cell line MC3T3-E1. Cells were grown in DMEM containing 10% fetal calf serum. Prostaglandin E2 (PGE2) production was determined by radioimmunoassay or by prelabeling cells with [3H]arachidonic acid, followed by high-performance liquid chromatography (HPLC) analysis of the labeled products released into the medium. Prostaglandin G/H synthase (PGHS) mRNAs were quantified by northern blot analysis using [32P]labeled cDNA probes. By HPLC, PGE2 was the major prostanoid produced under basal or stimulated conditions. No release of thromboxane or 6-keto-PGF1 alpha into the medium was detected. PGE2 production was stimulated approximately 7- to 14-fold by IL-1 (1 ng/ml) and 3- to 8-fold by TGF-alpha (30 ng/ml) after 24 h. In combination, however, IL-1 and TGF-alpha caused a synergistic 37- to 71-fold increase in PGE2 accumulation. PGHS-1 mRNA levels were maximally increased approximately 2- to 3-fold by IL-1 and 1.5 to 2.5-fold by TGF-alpha after 24 h; the combination of IL-1 and TGF-alpha produced only an additive 3- to 6-fold increase. Western blotting revealed a corresponding 3-fold increase in immunoreactive PGHS-1 protein in response to combined IL-1 and TGF-alpha. PGHS-2 mRNA was increased 1.4-fold by TGF-alpha at 1 h, and the combination of IL-1 and TGF-alpha caused a 1.7-fold increase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079657     DOI: 10.1002/jbmr.5650090607

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Regulation of periodontal ligament cell functions by interleukin-1beta.

Authors:  S Agarwal; C S Chandra; N P Piesco; H H Langkamp; L Bowen; C Baran
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Cyclooxygenase-2 gene and epithelial ovarian carcinoma risk.

Authors:  Bedia Agachan Cakmakoglu; Rukset Attar; Ozlem Timirci Kahraman; Altay Burak Dalan; Ahmet Cem Iyibozkurt; Ates Karateke; Erkut Attar
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

3.  Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.

Authors:  H Kawaguchi; C C Pilbeam; S J Vargas; E E Morse; J A Lorenzo; L G Raisz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index.

Authors:  Li-Li Xing; Zhen-Ning Wang; Li Jiang; Yong Zhang; Ying-Ying Xu; Juan Li; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

Authors:  H Kawaguchi; C C Pilbeam; G Gronowicz; C Abreu; B S Fletcher; H R Herschman; L G Raisz; M M Hurley
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

6.  Cyclooxygenase-2 and its regulation in inflammation.

Authors:  Y S Bakhle; R M Botting
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

Review 7.  Vitamin D receptor gene polymorphisms on the risk of tuberculosis, a meta-analysis of 29 case-control studies.

Authors:  Cheng Chen; Qiao Liu; Limei Zhu; Haitao Yang; Wei Lu
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

8.  The COX-2 selective blocker etodolac inhibits TNFα-induced apoptosis in isolated rabbit articular chondrocytes.

Authors:  Kousuke Kumagai; Mitsuhiko Kubo; Shinji Imai; Futoshi Toyoda; Tsutomu Maeda; Noriaki Okumura; Hiroshi Matsuura; Yoshitaka Matsusue
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.